Greenhaven Road Investment Management, L.P.

GREENWICH, CT · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$126.0M2026 Q3+ $3.5M options (notional, not included)
Positions19
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.89.7%

Greenhaven Road Investment Management, L.P. reported 19 positions worth $126.0M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: LFCR (14.6%).

10 / 19 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 LFCRLifecore Biomedical$18.9M14.57%2,868,881———
▸ 2 HGTYHagerty$18.7M14.44%1,389,977——+20.7%
▸ 3 KWYKingsway$14.6M11.29%1,539,187——-7.6%
▸ 4 CLBTCellebrite DI$12.8M9.85%1,133,567——-1.2%
▸ 5 PARPar Technology$10.8M8.37%787,888——+63.4%
▸ 6 BURBurford Capital$9.8M7.53%2,488,165——-6.1%
▸ 7 KKRKKR$9.0M6.98%99,108——+4.6%
▸ 8 CODICompass Diversified$8.3M6.37%756,205——+6.0%
▸ 9 ANABAnaptysbio$7.3M5.65%145,703——-8.0%
▸ 10 ASTSAST SpaceMobile$6.1M4.68%102,954——-44.6%

Pro Feature

The remaining 9 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Greenhaven Road Investment Management, L.P. hold as of Q3 2026?

Greenhaven Road Investment Management, L.P. reported 19 positions worth $126.0M in its Q3 2026 13F filing. Largest positions: LFCR (14.6%), HGTY (14.4%), KWY (11.3%), CLBT (9.9%) and PAR (8.4%).

What did Greenhaven Road Investment Management, L.P. buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Greenhaven Road Investment Management, L.P. sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.